FDA warns Ohio over execution drug; GSK gets permit for Memphis facility;

> The FDA has sent a letter to the Ohio Department of Rehabilitation and Correction warning that it must get FDA approval if it is thinking about importing a drug for executions. Story

> The FDA is warning providers not to use compounded drugs stored in Becton Dickinson ($BDX) 3 mL and 5 mL syringes because they are not approved as storage devices and drugs may be subpotent. Announcement

> GlaxoSmithKline ($GSK) has gotten a building permit for $2 million in modifications for a facility in Memphis, TN. Report

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.